AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 110.50
-1.50 (-1.34%)
Oct 9, 2025, 2:51 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 9.41 billion as of October 10, 2025. Its market cap has increased by 113.11% in one year.
Market Cap
9.41B
Enterprise Value
8.11B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
110.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 9.41B, an increase of 84.57%. That is a compound annual growth rate of 31.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 9.41B | 122.70% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |